DONATION: Decrease Artery Occlusion by Distal Radial Arterial Cannulation in ACS Patients

Sponsor
Shenzhen People's Hospital (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT05255939
Collaborator
(none)
1,500
1
2
23.1
65

Study Details

Study Description

Brief Summary

The site of arterial access for coronary angiography and intervention has been the focus of research for decades as it is the source of major complications. Transradial access (TRA) reduces complications among patients undergoing percutaneous coronary procedures but is reported with the complication of radial artery occlusion (RAO) that limits the radial artery for future needs.

Distal radial access (dTRA) has recently gained global popularity as an alternative access route for vascular procedures. Among the benefits of dTRA are the low risk of entry site bleeding complications, the low rate of radial artery occlusion, and improved patient and operator comfort.

This study aims to reveal the feasibility and safety of dTRA and routine TRA procedures in acute coronary syndrome patients. The primary endpoints are forearm radical occlusion rate and major adverse cardiovascular events (MACEs) in the two groups, respectively. Investigators will also focus on puncture success in diagnostic and interventional cases, rate of One attempt success, access time, procedure time, crossover rate, contrast dose of patients, fluoroscopy time and dose, and healthcare cost of each group.

Condition or Disease Intervention/Treatment Phase
  • Procedure: distal TRA group
  • Procedure: conventional TRA group
N/A

Study Design

Study Type:
Interventional
Anticipated Enrollment :
1500 participants
Allocation:
Non-Randomized
Intervention Model:
Parallel Assignment
Masking:
Single (Participant)
Primary Purpose:
Treatment
Official Title:
Decrease Artery Occlusion by Distal Radial Arterial Cannulation in ACS Patients
Anticipated Study Start Date :
Mar 1, 2022
Anticipated Primary Completion Date :
Feb 1, 2024
Anticipated Study Completion Date :
Feb 1, 2024

Arms and Interventions

Arm Intervention/Treatment
Experimental: dTRA group

Investigators perform percutaneous coronary intervention by dTRA

Procedure: distal TRA group
dTRA for PCI procedure to ACS patients.

Other: TRA group

Investigators perform percutaneous coronary intervention by conventional TRA

Procedure: conventional TRA group
Conventional TRA for PCI procedure to ACS patients

Outcome Measures

Primary Outcome Measures

  1. Forearm radical occlusion [during procedure]

    Doppler ultrasound to determine whether patients suffer forearm radial occlusion

  2. MACEs [during procedure]

    Major Adverse Cardiovascular Events, including cardiovascular death, myocardial infarction and heart failure.

Secondary Outcome Measures

  1. Rate of One attempt success [during procedure]

    Rate of One attempt success of 2 kinds of procedure

  2. Access time [during procedure]

    Access time of 2 kinds of procedure

  3. Procedure time [during procedure]

    Procedure time of 2 kinds of procedure

  4. Crossover rate [during procedure]

    Crossover rate of 2 kinds of procedure

  5. Contrast dose [during procedure]

    Contrast dose of 2 kinds of procedure

  6. Fluoroscopy dose [during procedure]

    Fluoroscopy dose of 2 kinds of procedure

  7. hand hematoma [during procedure]

    hand hematoma rate of 2 kinds of procedure

  8. The total cost in hospitalization [up to 2 years]

    Healthcare cost .

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 85 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • presence of a pulse in the snuffbox
Exclusion Criteria:
  • Absence of pulse

  • Ultrasound indication of arterial occlusion or severe calcification

  • Severe forearm artery malformation

  • Patients with severe liver and renal failure, or abnormal coagulation function

  • Established cardiogenic shock

  • History of previous coronary artery bypass grafting and radial artery use.

  • Raynaud's disease in the medical history

Contacts and Locations

Locations

Site City State Country Postal Code
1 Shenzhen People's hospital Shenzhen Guangdong China 518000

Sponsors and Collaborators

  • Shenzhen People's Hospital

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Shenzhen People's Hospital
ClinicalTrials.gov Identifier:
NCT05255939
Other Study ID Numbers:
  • DONATION
First Posted:
Feb 25, 2022
Last Update Posted:
Feb 25, 2022
Last Verified:
Feb 1, 2022
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Shenzhen People's Hospital
Additional relevant MeSH terms:

Study Results

No Results Posted as of Feb 25, 2022